Search

everythinglearnresearchcommunity

for

Search:↓

Better hair care products are needed to protect against grooming and chemical damage.

New model shows muscle affects hair loss differently in men and women.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Hair growth and health are influenced by stress and hormones.

Low serum ferritin levels are linked to hair loss in women.

Higher serum ferritin levels than currently used might be needed to rule out iron deficiency in women with hair loss.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

High concentration Minoxidil and Carboxygas effectively treated resistant hair loss with no side effects.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

The article concludes that studying how skin forms is key to understanding skin diseases and improving regenerative medicine.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Hair loss caused by genetics and hormones; more research needed for treatments.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Noggin is necessary to start the hair growth phase in skin after birth.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

A mother's PPARγ is crucial for preventing harmful milk that can cause inflammation and growth problems in babies.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Oxidative stress damages hair and contributes to aging, and managing it can help maintain hair health.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Mice can grow new hair follicles after skin wounds through a process not involving existing hair stem cells, but requiring more research to understand fully.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Some children are born with unusually short, fine hair because their hair growth phase is short, but this often gets better by itself during puberty.